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The liver serves as the key organ for the removal and detoxification of bacterial endotoxins that are
continously absorbed in small amounts from the gastrointestinal tract. This paperpostulates that liverinjury
impairs this detoxification process leading to further liver damage and systemic effects as well. Evidence is
reviewed to support the contention that endotoxin may be a major common pathway for liver injury by a
variety of agents, and methods of reducing endotoxicity of gut origin are proposed. Finally, a new solid
phase radioimmunometric assay for E. coli 026 is described and its usefulness as a gut marker suggested.
It is an honor to participate in this Festshcrift for Gerald Klatskin. In addition to
providing his trainees with an unsurpassed experience in the clinical aspects of liver
disease, he began many of us in directions we were to follow in the laboratory in later
years. My own interest in Kupffer cell function, and the detoxification ofendotoxins
from the gut were stimulated by Dr. Klatskin's insistence inthe early 1960s thatfatty
infiltration alone would not explain the extent ofdamage and fibrosis resultingafter
certain liver injuries. Since the liver stands as an effective filter of bacterial products
arising in the gastrointestinal tract, the possibility that animpairment oftheability to
perform this function might initiate or perpetuate hepatic injury has interested our
laboratory over the years. To this end, we have sought evidence for a relationship
between liver injury and altered endotoxin detoxification. Additionally, we have
examined whether methods of modifying endotoxin toxicity modify acute hepatic
injury by other toxins. While the role ofendotoxin in liver disease has never been in
the mainstream of liver research in this country, much recent work would tend to
support the importance of such a relationship [1].
HYPOTHESIS
The postulates that form the basis of the hypothesis relating enteric endotoxin to
liver injury are as follows:
a. Portal vein endotoxemia is a normal state; b. Theliver prevents the lipopolysac-
charide (LPS) of gram-negative bacteria from becoming systemic; c. Liver injury
impairs endotoxin detoxification leading to further liver injury, and entry into the
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All rights of reproduction in any form reserved.systemic circulation; and d. Modification of endotoxicity should lessen liver injury
from other agents.
Figure 1 depicts the hypothesis and some ofits implications. Essentially, endotoxin
from the intestine is constantly being absorbed and carried to the liverfor detoxifica-
tion. If the detoxification mechanisms are impaired, endotoxin may reach concentra-
tions in the liver that cause further injury which serves, in a circular fashion, to impair
detoxification further. In addition, endotoxin may spill over into the systemic
circulation and may contribute to such extra-hepatic effects of liver disease as fever,
clotting abnormalities, and kidney failure. A key function of the liver is the
sequestration of bacterial and dietary antigens entering the portal circulation, thus
preventing them from reaching antibody forming tissue such as the spleen. Endo-
toxin that spills over into the systemic circulation in liver injury may stimulate such
antibody formation and has been felt by some observers to be responsible for the
hyperglobulinemia that accompanies chronic liver disease [2]. Since endotoxins have
known stimulatory effects on lymphocytes as well, their role in observed T and B-cell
abnormalities in hepatic disease needs further definition. While tissue and serum
factors are important in endotoxin clearance, the key to the impairment of hepatic
endotoxin detoxification seems to be the reticuloendothelial system activity which is
depressed after toxic injury, alcohol administration, and fatty infiltration [3,4].
EVIDENCE OF SYNERGISM BETWEEN ENDOTOXIN
AND OTHER HEPATOTOXINS
Historically, a postulated relationship between intestinal flora and dietary liver
injury goes back many years. In 1954, Luckey demonstrated that conventional rats
fed a necrogenic diet died of massive liver necrosis in 33 days, while germ-free
animals suffered no hepatic damage over the same period [5]. Rutenberg and his
associates showed significant modification of fibrosis and cirrhosis by the non-
absorbable antibiotic neomycin, suggesting that systemic absorption was not impor-
tant in the antibiotic effect [6]. In an elegant and important study in 1964, Broitman
and his co-workers demonstrated that it was the presence of intra-intestinal endo-
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FIG. 1. Schematic representation of endotoxin effects in liver injury.
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toxin rather than the intact bacteria that was crucial to the development of choline-
deficiency cirrhosis [7]. These investigators confirmed the protective effect of
neomycin on the development of the lesion, but showed that the simple addition of
purified E. coli lipopolysaccharide to the drinking water of choline-deficient rats
abolished this protection, and allowed fibrosis and subsequent cirrhosis to develop
unimpeded.
Further, solid evidence exists that injured livers have a markedly increased
sensitivity to the toxic effects of bacterial endotoxins. Rats receiving sublethal doses
of carbon tetrachloride (CCL4) showed a tenfold increase in lethality to E. coli
endotoxin administration [8], and the significant effect of CCL4 on reducing the
endotoxin-detoxifying capacity of liver homogenate has been demonstrated as well
[9]. In 1968, our laboratory studied the effects of endotoxin in rats on a choline-
deficient diet and observed not only a reduction in the L.D.50 from 2.5 mg to 0.25 mg
but also that transaminase elevations occurred in these animals at doses that were
totally innocuous to animals on choline-supplemented diets[10]. The mechanisms by
which endotoxin exerts its damaging effects are not altogether clear, but involve both
direct and mediated mechanisms and have been previously summarized [1].
ENDOTOXEMIA IN LIVER DISEASE
Key to the hypothesis suggesting a role for endotoxins in determining the
magnitude of liver injury is the assumption that lipopolysaccharide is absorbed from
the gut. Earlier experimental evidence was somewhat conflicting on the point of
endotoxin absorption. In one study using Cr5' labelled lipopolysaccharide, no
evidence of absorption was found[11], while using p32 labelled bacteria to produce the LPS, the endotoxin regularly appeared in the tissues [12]. Work from our
laboratory usingthe isolated everted gut sac ofthe rat showed labelled LPS regularly
passes transmurally in small amounts, and rather than being a passive diffusion, a
saturable carrier mechanism appears to exist [13]. Furthermore, the material passing
through the gut wall retains both its toxic and immunogenic properties. Using the
limulus lysate gelation method of detecting minute quantities of circulating endo-
toxin, positive tests for endotoxin have been obtained in portal blood sampled at the
time of surgery in up to 95 percent of patients tested [14]. Theoretically, in liver
disease, endotoxin absorption and toxicity might be increased because of a relative
decrease in the amount of bile salts produced. Sodium deoxycholate treatment
diminishes the capacity of endotoxin to kill chick embryos [15], and it has recently
been shown that deoxycholate is often absent in the bile of patients with alcoholic
cirrhosis [16]. In the past few years, a number of studies have been reported
correlating systemic endotoxemia in liver disease with extra-hepatic manifestations
of liver failure. The most notable association has been with the functional renal
failure associated with massive liver necrosis. Wilkinson and his colleagues showed
an excellent correlation of limulus positivity with depression in parameters of renal
function in patients
with acute liver injury [17].
A similar correlation has been noted
in patients
with alcoholic cirrhosis [18].
Fever has been shown by Tisdale and
Klatskin to be a significant feature of alcoholic liver disease [19] and limulus
positivity
can be shown correlate with presence and duration of the febrile state in
these patients [20]. Tarao and his Japanese colleagues have found high titers of
limulus-positive
material in the ascites of patients with alcoholic hepatitis and
postulate
that the ascites serves as a major source of endotoxemia in the peripheral
circulation [21]. These investigators noted that death occurred within 6 months in 48
percent
of those with lysate positivity as opposed to
16 percent in those without
129detectable endotoxin. A provocative study of patients with Reyes Syndrome regu-
larly found endotoxin in the peripheral circulation and the highest titers were
associated with death [22]. Since endotoxin causes the same depression ofmitochon-
drial function that is found in this disease [23], it is tempting to attach etiological
significance to systemic endotoxemia in this syndrome.
SIGNIFICANCE AND NEW DIRECTIONS
The key question that arises in all of these descriptive clinical studies is the
significance of lipopolysaccharide in the peripheral circulation in liver disease. Is
endotoxemia causative in further decompensating a damaged liver, or is its presence
simply another reflection ofliverdamage itself, and as aconsequence, oflittle clinical
significance? One approach to this problem would be to test whether measures aimed
at modifying endotoxin toxicity would also modify liver injury by other hepatotoxic
agents. If significant protection could be demonstrated with methods aimed at
reducing endotoxicity alone, then theimportance oflipopolysaccharide in promoting
hepatic damage would be more likely. Table 1 summarizes the methods presently
available that might modify endotoxicity in liver disease. While not all of these
methods have been shown to modify hepatic damage, evidence now exists for the
efficacy of several. The creation of the state of endotoxin tolerance through the
administration of increasingly large doses of a single lipopolysaccharide over time
protects against challenge with other endotoxins [24]. In rats made tolerant and then
challenged acutely with carbon tetrachloride, the liver injury was significantly
modified [25]. After a sublethal dose ofCCL4, the mean SGPT value in the tolerant
animals at 24 hours was 57 compared with 241 in the non-tolerant pair-fed controls.
Striking histological protection was noted at the same time in the livers of the
endotoxin tolerant rats. With the advent of mutant, rough strains ofgram-negative
bacteria that contain common, core material, it may be possible to activelyimmunize
against a broad spectrum ofendotoxin strains [26]. Attempts to decrease endotoxin
absorption from the gut offers another approach to modifying its hepatic toxicity.
The intra-intestinal pool available for absorption could be decreased by antibiotic
suppression of bacteria, disruption of the lipopolysaccharide with added bile salts
[27], orthe use ofcholestyramine resin which tightly bindsendotoxin and prevents its
toxicity [28]. Once endotoxin gains entrance to the circulation, removal of the LPS
might reduce its toxic effects. Hemoperfusion with activated charcoal columns has
been shown to prolong life in dogs after hepatectomy [29]. Since charcoal efficiently
removes labelled endotoxin from solutions, it is possible that this removal might
explain the benefits of resin hemoperfusion. Lastly, polymyxin B has been shown to
TABLE I
1. Increasing Resistance
a. Heterologous tolerance
b. Specific immunization
2. Decreasing Gastrointestinal Absorption
a. Non-absorbable antibiotics
b. Cholestyramine resin
c. Bile salts
3. Removal of Circulating Endotoxin
a. Activated charcoal hemoperfusion
b. Polymyxin B inactivation
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have a protective effect against endotoxicity that is independent ofits anti-bacterial
action and that appears related to its ability to disrupt the LPS complex[30]. To test
whether this anti-endotoxin protects against liver injury, rats were pre-treated with
polymyxin B or gentamicin; an antibiotic with a similar antibacterial spectrum but
without an effect on endotoxin itself. Striking biochemical and histological liver
protection was noted in the animals given polymyxin B, and challenged with CCL4 as
compared to the control groups [31].
The biggest obstacle to further delineating the role of endotoxin in liver injury by
more direct methods has been thelack ofa suitable quantitative assayfor gut derived
LPS. The limulus assay is at best qualitative and its specificity stillis questioned[32].
Other bioassays in animals, such as lead acetate enhancement of endotoxicity, are
cumbersome and have the difficulties inherent in any such assay.
In our attempt to overcome these problems, we have developed an immunoradio-
metric method (IRMA) forthe specific detection and quantitation ofendotoxinfrom
E. coli 026 [33]. The conventional radioimmunoassay involves labelling ofan antigen
with a marker, usually a radioactive isotope of iodine. The labelled antigen is then
allowed to compete with an unknown amount of antigen for interaction with
antibody. lodination generally requires the presence of peptide moieties within the
antigen molecule; and while protein is present in crude as well as commercial
endotoxin, the pure antigen is alipopolysaccharide containing no protein. Because of
the difficulty in purifying and labelling this complex molecule, the antigen labelling
RIA technique was abandoned infavor ofusing a labelled antibodyin animmunora-
diometric assay [34]. Since antibody may be separated and concentrated from the
sera of animals and the peptide portions ofglobulin easily iodinated, a reproducible
test for the detection of endotoxin could be developed. Because it seemed most
desirable to measure a known endotoxin marker, E. coli 026 lipopolysaccharide was
used as the test substance. Inthe procedure, antibodyis first immobilized on the walls
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FIG. 2. Clearance of E. coli 026endotoxin afterintraperitoneal injection(0.lmg). Concentration in ng/ml is plotted
against time.
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of small volume plastic wells, and the unlabelled antigen is then allowed to react with
the antibody coating the wells. After the unattached antibody is removed, labelled
antibody is added and each well counted. Using known concentrations of the
endotoxin, a curve of standard concentrations can be plotted. We have found that
this method detects E. coli 026 in serum down to less than 1 nanogram per ml, and
that no cross-reactivity occurs with other E. coli endotoxins, or LPS from S. typhosa
0901 or S. marceseus. Using this technique in groups of 5 rats each, the clearance of
0.1 mg of E. coli endotoxin given intraperitoneally is shown in Fig. 2. For the first
hours, the rate of clearance was slow and by 6 hours, 1200 ng/ml was present. By 24
hours, 15 ng/ml remained and clearance was complete at 48 hours. When limulus
lysate assays were performed on the same samples, it was found that the IRMA was
more sensitive below 10 ng/ml. Since E. coli 026 is not a normal gut inhabitant, its
placement in the gut ofanimals serves for the first time as a quantitative marker for
the appearance, distribution, and possible modification ofendotoxemia ofgut origin.
Despite all the evidence supporting a role for gut derived endotoxin in the
initiation and perpetuation ofliver injury, certaintheoretical difficulties remain to be
answered. For example, if endotoxin is constantly entering into the circulation in
liver disease, one might expect tolerance orimmunityto develop and to be protective
against further injury. Since LPS stimulates reticuloendothelial function, it is again
uncertain why reticuloendothelial function is depressed in chronic liver disease. The
new radioimmunoassay for E. coli 026 may allow for the first time a study ofthese
perplexing but most important problems.
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